Category | Property | Total | Positive | Negative | Train | Test |
---|---|---|---|---|---|---|
Basic physicochemical property | LogS | 5220 | – | – | 4116 | 1104 |
LogD7.4 | 1031 | – | – | 773 | 258 | |
LogP | Â | Â | Â | Â | Â | |
Absorption | Caco-2 | 1182 | – | – | 886 | 296 |
Pgp-inhibitor | 2297 | 1372 | 925 | 1723 | 574 | |
Pgp-substrate | 1252 | 643 | 609 | 939 | 313 | |
HIA | 970 | 818 | 152 | 728 | 242 | |
F (20%) | 1013 | 759 | 254 | 760 | 253 | |
F (30%) | 1013 | 672 | 341 | 760 | 253 | |
Distribution | PPB | 1822 | – | – | 1368 | 454 |
VD | 544 | – | – | 408 | 136 | |
BBB | 2237 | 540 | 1697 | 1678 | 559 | |
Metabolism | CYP 1A2-inhibitor | 12,145 | 5713 | 6432 | 9145 | 3000 |
CYP 1A2-substrate | 396 | 198 | 198 | 297 | 99 | |
CYP 3A4-inhibitor | 11,893 | 5047 | 6846 | 8893 | 3000 | |
CYP 3A4-substrate | 1020 | 510 | 510 | 765 | 255 | |
CYP 2C9-inhibitor | 11,720 | 3960 | 7760 | 8720 | 3000 | |
CYP 2C9-substrate | 784 | 278 | 506 | 626 | 156 | |
CYP 2C19-inhibitor | 12,272 | 5670 | 6602 | 9272 | 3000 | |
CYP 2C19-substrate | 312 | 156 | 156 | 234 | 78 | |
CYP 2D6-inhibitor | 12,726 | 2342 | 10,384 | 9726 | 3000 | |
CYP 2D6-substrate | 816 | 352 | 464 | 611 | 205 | |
Excretion | Clearance | 544 | – | – | 408 | 136 |
T1/2 | 544 | – | – | 408 | 136 | |
Toxicity | hERG | 655 | 451 | 204 | 392 | 263 |
H-HT | 2171 | 1435 | 736 | 1628 | 543 | |
Ames | 7619 | 4252 | 3367 | 5714 | 1905 | |
Skin sensitivity | 404 | 274 | 130 | 323 | 81 | |
Rat oral acute toxicity | 7397 | – | – | 5917 | 1480 | |
DILI | 475 | 236 | 239 | 380 | 95 | |
FDAMDD | 803 | 442 | 361 | 643 | 160 |